The Significance of a Positive Fetal Fibronectin in the Setting of a Normal Cervical Length in Twin Pregnancies

Abstract

To estimate the risk of preterm birth in asymptomatic women with twin pregnancies with a normal cervical length (CL) and a positive fetal fibronectin (fFN), we reviewed a retrospective cohort of twin pregnancies delivered in our practice from 2005 to 2010. Patients were screened from 22 to 32 weeks with CL and fFN at 2- to 4-week intervals. We examined 244 patients with twin pregnancies and a normal CL (>25 mm) between 22 and 32 weeks and compared outcomes based on the fFN result. Fourteen (5.7%) patients had a positive fFN and 230 (94.3%) patients had a negative fFN. Positive fFN was associated with an increased the risk of spontaneous preterm birth < 37 weeks (85.7% versus 38.3%, p = 0.001), < 35 weeks (50% versus 11.8%, p <  0.001), < 34 weeks (35.7% versus 6.9%, p <  0.001), and < 32 weeks (21.4% versus 2.2%, p <  0.001). On adjusted analysis, a positive fFN was independently associated with preterm birth < 32 weeks (odds ratio 6.8, 95% confidence interval 1.42, 32.2) and gestational age at delivery (p = 0.001). In the setting of a normal CL, a positive fFN is significantly associated with preterm birth in asymptomatic twin pregnancies. Contingency model screening of fFN in asymptomatic twin pregnancies solely based on CL evaluation may fail to identify a cohort of at-risk patients.

Keywords

twins - preterm birth - fetal fibronectin - cervical length

• References

• 1 Martin JA, Kung HC, Mathews TJ , et al. Annual summary of vital statistics: 2006. Pediatrics 2008; 121: 788-801
• 2 Goldenberg RL, Iams JD, Miodovnik M , et al ; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The preterm prediction study: risk factors in twin gestations. Am J Obstet Gynecol 1996; 175 (4 Pt 1) 1047-1053
• 3 Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol 1999; 94: 450-454
• 4 Imseis HM, Albert TA, Iams JD. Identifying twin gestations at low risk for preterm birth with a transvaginal ultrasonographic cervical measurement at 24 to 26 weeks' gestation. Am J Obstet Gynecol 1997; 177: 1149-1155
• 5 Guzman ER, Walters C, O'reilly-Green C , et al. Use of cervical ultrasonography in prediction of spontaneous preterm birth in twin gestations. Am J Obstet Gynecol 2000; 183: 1103-1107
• 6 Fox NS, Saltzman DH, Klauser CK, Peress D, Gutierrez CV, Rebarber A. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol 2009; 201: 313; e1-e5
• 7 Terrone DA, Rinehart BK, Kraeden U, Morrison JC. Fetal fibronectin in symptomatic twin gestations. Prim Care Update Ob Gyns 1998; 5: 179
• 8 Singer E, Pilpel S, Bsat F, Plevyak M, Healy A, Markenson G. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol 2007; 109: 1083-1087
• 9 Wennerholm UB, Holm B, Mattsby-Baltzer I , et al. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol 1997; 104: 1398-1404
• 10 Gibson JL, Macara LM, Owen P, Young D, Macauley J, Mackenzie F. Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing. Ultrasound Obstet Gynecol 2004; 23: 561-566
• 11 Hincz P, Wilczynski J, Kozarzewski M, Szaflik K. Two-step test: the combined use of fetal fibronectin and sonographic examination of the uterine cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet Gynecol Scand 2002; 81: 58-63
• 12 Audibert F, Fortin S, Delvin E , et al. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour. J Obstet Gynaecol Can 2010; 32: 307-312
• 13 Schmitz T, Maillard F, Bessard-Bacquaert S , et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol 2006; 194: 138-143
• 14 Rose CH, McWeeney DT, Brost BC, Davies NP, Watson WJ. Cost-effective standardization of preterm labor evaluation. Am J Obstet Gynecol 2010; 203: 250; e1-e5
• 15 Iams JD, Goldenberg RL, Meis PJ , et al ; National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996; 334: 567-572
• 16 Yost NP, Bloom SL, Twickler DM, Leveno KJ. Pitfalls in ultrasonic cervical length measurement for predicting preterm birth. Obstet Gynecol 1999; 93: 510-516
• 17 Roman AS, Koklanaris N, Paidas MJ, Mulholland J, Levitz M, Rebarber A. “Blind” vaginal fetal fibronectin as a predictor of spontaneous preterm delivery. Obstet Gynecol 2005; 105: 285-289
• 18 Stafford IP, Garite TJ, Dildy GA , et al. A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing. Am J Obstet Gynecol 2008; 199: 131; e1-e4
• 19 Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106: 181-189
• 20 Crowther CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev 2001; (1) CD000110
• 21 Rouse DJ, Caritis SN, Peaceman AM . et al ; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007; 357: 454-461
• 22 Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-469
• 23 Bolt LA, Chandiramani M, De Greeff A, Seed PT, Kurtzman J, Shennan AH. The value of combined cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high-risk women. J Matern Fetal Neonatal Med 2011; 24: 928-932